**Abstract**

Tuberous sclerosis complex (TSC) is an inherited autosomal dominant disorder caused by mutations in either *TSC1* or *TSC2*. TSC patients display severe neurological symptoms such as epilepsy and autism spectrum disorder (ASD). We previously reported that *Tsc2* heterozygous knockout (*Tsc2*(+/-)) mice exhibited ASD-like social impairment which were improved by mTOR inhibitor administration. In the present study, whole-genome gene expressions were analyzed in the *Tsc2*(+/-) brains for elucidating the molecular mechanism of ASD.

Total RNAs were prepared from whole brains of male *Tsc2*(+/-) and wild-type mice administrated with rapamycin or saline. Whole-genome expression assay was performed using Illumina MouseRef-8 Expression BeadChips. The list of candidate transcripts obtained from the whole-genome expression assay was subjected to gene ontology analysis with MetaCore.

Expression levels of 1,100 transcripts, accounting for approximately 4.5% of analyzed transcripts, were altered in *Tsc2*(+/-) mice and reversed by rapamycin. These transcripts were enriched in neoplasm formation and inflammation. Regarding the mTOR pathway, the expression level of *Tsc2* was reduced to a half of wild-type mice. Conversely, *Tsc1* expression level was increased, and was suppressed by rapamycin administration. Gene expressions of *Eef2k*, *Deptor* and *Ulk1* were increased and all of these increases were also suppressed by rapamycin. Our findings suggested an increased propensity for tumorgenesis and inflammation in *Tsc2*(+/-) brain.
